| Distinct phenotype of SARS-CoV-2 Omicron BA.1 in human primary cells but no increased host range in cell lines of putative mammalian reservoir species | Virus research |  | | 2023 | 50 | 195 |
|
| Sequential infections with rhinovirus and influenza modulate the replicative capacity of SARS-CoV-2 in the upper respiratory tract | Emerging microbes & infections | | | 2022 | 377 | 415 |
|
| Diagnostic accuracy of two commercial SARS-CoV-2 antigen-detecting rapid tests at the point of care in community-based testing centers | PLOS ONE | | | 2021 | 376 | 491 |
|
| Puumala Virus Infection in Family, Switzerland | Emerging Infectious Diseases | | | 2021 | 463 | 437 |
|
| Immunological assessment of pediatric multisystem inflammatory syndrome related to COVID-19 | Journal of the Pediatric Infectious Diseases Society | | | 2021 | 337 | 229 |
|
| Validation and clinical evaluation of a SARS-CoV-2 surrogate virus neutralisation test (sVNT) | Emerging Microbes & Infections | | | 2020 | 468 | 316 |
|
| Validation of a commercially available SARS-CoV-2 serological immunoassay | Clinical Microbiology and Infection | | | 2020 | 530 | 367 |
|
| Culture-Competent SARS-CoV-2 in Nasopharynx of Symptomatic Neonates, Children, and Adolescents | Emerging Infectious Diseases | | | 2020 | 502 | 304 |
|
| Diagnostic accuracy of Augurix COVID-19 IgG serology rapid test | European Journal of Clinical Investigation | | | 2020 | 463 | 495 |
|
| Development and Validation of the Elecsys Anti-SARS-CoV-2 Immunoassay as a Highly Specific Tool for Determining Past Exposure to SARS-CoV-2 | Journal of Clinical Microbiology | | | 2020 | 427 | 300 |
|
| Head-to-head accuracy comparison of three commercial COVID-19 IgM/IgG serology rapid tests | Journal of Clinical Medicine | | | 2020 | 383 | 241 |
|
| Sars-cov-2 inhibition by sulfonated compounds | Microorganisms | | | 2020 | 304 | 198 |
|
| Daily viral kinetics and innate and adaptive immune response assessment in COVID-19: a case series | mSphere | | | 2020 | 526 | 237 |
|
